Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

LEXX Lexaria Bioscience Corporation

3,18

-0,37 (-10,42%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:44:07

Verzögert um 15 Minuten

Form POS AM - Post-Effective amendments for registration statement

nullnullnull

Lexaria Bioscience (NASDAQ:LEXX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience (NASDAQ:LEXX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Lexaria Bioscience Charts.

News Lexaria Bioscience Corporation

Form DEF 14A - Other definitive proxy statements
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 1 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 16 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities
Freitag 16 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 30 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 24 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Mittwoch 24 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Donnerstag 18 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 12 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream
Donnerstag 11 Januar 2024 (4 Monate vor) • GlobeNewswire Inc.

Weitere Lexaria Bioscience Corporation News-Artikel

Deutsche Telekom

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen